C&R Research Inc. (359090.KQ)
KOSDAQ · KRW · Healthcare · Health Information Services
₩2,160 (-0.69%) as of
Key statistics
- Market cap
- 24.83B
- Dividend yield
- 2.27%
- 52-week range
- 1,667.00 – 5,890.00
- Beta
- 0.01
- Revenue (TTM)
- 63.55B
- Profit margin
- 2.61%
- Volume
- 1.88k
About C&R Research Inc.
C&R Research Inc. engages in the of clinical development for pharmaceuticals and medical devices. The company's therapeutic area comprises oncology, cardiovascular, endocrinology, dermatology, central nervous system, ophthalmology, and rare disease.The company was founded in 1997 and is based in Seoul, South Korea.
- Sector
- Healthcare
- Industry
- Health Information Services
- Headquarters
- Seoul, South Korea
- Employees
- 482
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.